![Convalescent plasma in patients admitted to hospital with COVID-19 (RECOVERY): a randomised controlled, open-label, platform trial - The Lancet Convalescent plasma in patients admitted to hospital with COVID-19 (RECOVERY): a randomised controlled, open-label, platform trial - The Lancet](https://els-jbs-prod-cdn.jbs.elsevierhealth.com/cms/asset/d718af38-6ed3-4005-8765-4d26d8f956df/gr2.jpg)
Convalescent plasma in patients admitted to hospital with COVID-19 (RECOVERY): a randomised controlled, open-label, platform trial - The Lancet
![Tocilizumab in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial - The Lancet Tocilizumab in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial - The Lancet](https://els-jbs-prod-cdn.jbs.elsevierhealth.com/cms/asset/94597f5b-8f00-4c9a-9442-ec00415b36da/gr1.jpg)
Tocilizumab in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial - The Lancet
![11235381_648072375334884_7342977087553086471_n.jpg (960×679) | Car design sketch, Car design, Design sketch 11235381_648072375334884_7342977087553086471_n.jpg (960×679) | Car design sketch, Car design, Design sketch](https://i.pinimg.com/originals/55/d5/ee/55d5eeca72df6c49ae5b1d62e00bd5f4.jpg)
11235381_648072375334884_7342977087553086471_n.jpg (960×679) | Car design sketch, Car design, Design sketch
![Convalescent plasma in patients admitted to hospital with COVID-19 (RECOVERY): a randomised controlled, open-label, platform trial - The Lancet Convalescent plasma in patients admitted to hospital with COVID-19 (RECOVERY): a randomised controlled, open-label, platform trial - The Lancet](https://els-jbs-prod-cdn.jbs.elsevierhealth.com/cms/attachment/26344476-0970-43b1-807f-18755f7ce7eb/gr1.gif)